| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.7 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.7 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |